Johnson & Johnson said some of its Procrit anemia treatment was found diluted to greatly reduce the amount of active medicine in the solution, the latest in a string of drug counterfeiting incidents ...

DEAR DR. ROACH: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...

Dear Dr. Roach: I am a patient with myelofibrosis, and have been under treatment for over three years. At one time I was receiving blood transfusions every three weeks and taking Jakafi (very ...

A black-box warning issued by the FDA may curtail aggressive use of marketed anemia drugs Aranesp and Epogen from Amgen, as well as Procrit, sold by Johnson & Johnson’s Ortho Biotech unit. The revised ...

Epoetin alfa 10000 Units, 20000 Units; per mL; soln for IV or SC inj; contains albumin (human) and benzyl alcohol. Individualize (see full labeling for titration). CKD: initially 50–100 Units/kg 3 ...

(CN) - The Supreme Court on Monday refused to block a lawsuit against a Johnson & Johnson subsidiary by salesmen who accused the company of giving kickbacks to doctors for prescribing its anemia drug ...

Another potential safety problem for anemia drugs: Johnson & Johnson announced that Procrit was linked to the deaths of some patients in a stroke study. Participants in the European trial were given ...

THOUSAND OAKS, Calif., Sept. 24 /PRNewswire/ -- Amgen (Nasdaq: AMGN) announced today that certain lots of EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily recalled from specialty ...

BRIDGEWATER, N.J., March 7 /PRNewswire/ -- Ortho Biotech Products, L.P. today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the U.S. Food and Drug ...